Cite
MLA Citation
Kishan K. Patel et al.. “Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma.” Leukemia & lymphoma, vol. 61, no. 14, 2020, pp. 3387–3394. http://access.bl.uk/ark:/81055/vdc_100120102769.0x00003a